Edwards Lifesciences (EW) Raw Materials (2010 - 2026)

Edwards Lifesciences has reported Raw Materials for 13 years, with the latest figure at $210.5 million in Q2 2026.

• On a quarterly basis, Raw Materials fell 15.73% year-over-year to $210.5 million in Q2 2026; TTM through Jun 2026 was $210.5 million, a 15.73% decrease from a year earlier, with the FY2025 full-year figure at $196.6 million, down 18.46% from the prior year.
• Raw Materials was $210.5 million for Q2 2026 at Edwards Lifesciences, up from $202.4 million in the prior quarter.
• The five-year high for Raw Materials was $280.0 million in Q1 2024, with the low at $196.3 million in Q4 2023.
• Average Raw Materials over 4 years is $231.0 million, with a median of $233.5 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2026: Raw Materials climbed 22.82% in 2024, then declined 21.91% in 2026.
• Over 4 years, Raw Materials stood at $196.3 million in 2023, then climbed by 22.82% to $241.1 million in 2024, then declined by 18.46% to $196.6 million in 2025, then increased by 7.07% to $210.5 million in 2026.
• The last three Raw Materials figures came in at $210.5 million (Q2 2026), $202.4 million (Q1 2026), and $196.6 million (Q4 2025), per Business Quant data.